CD81 as a tumor target.

Area of Science:

• Cell Biology
• Immunology
• Oncology

Background:

• CD81 is a tetraspanin protein involved in membrane organization, protein trafficking, cellular fusion, and cell-cell interactions.
• In the immune system, CD81 regulates immune synapse formation, receptor clustering, and signaling, mediating both adaptive and innate immune suppression.
• CD81 acts as a cellular gateway for pathogens like hepatitis C virus and Plasmodium, and influences susceptibility to Listeria infection.

Purpose of the Study:

• To discuss the multifaceted roles of CD81 in biological processes.
• To highlight the involvement of CD81 in cancer progression, including tumor growth and metastasis.
• To explore the potential of CD81 as a therapeutic target in cancer treatment.

Main Methods:

• Review of existing literature on CD81 functions.
• Analysis of CD81 expression patterns in various cancer types.
• Discussion of CD81's association with other proteins and its role in signaling platforms.

Main Results:

• CD81 is implicated in regulating cell migration and invasion, contributing to cancer progression.
• CD81 is expressed across a wide range of cancers, with altered expression correlating with patient prognosis.
• CD81's association with other tetraspanins and cell-specific proteins forms signaling platforms that dictate its diverse functions.

Conclusions:

• CD81 plays a critical role in both normal cellular functions and disease states, particularly in cancer.
• The involvement of CD81 in tumor growth and metastasis suggests its potential as a therapeutic target.
• Further research into CD81's mechanisms in cancer could lead to novel treatment strategies.